This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

LOMUCIN - Asthma

Genaera Corporation

Drug Names(s): talniflumate - Asthma

Deal Structure: 15% revenue share in U.S., Europe and Japan assumes Genaera will partner with larger pharmaceutical company in the Asthma market.

Partners: Laboratorios Bago

LOMUCIN - Asthma News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug